Despite their different etiologies and clinical as well as pathological manifestations, most neurodegenerative disorders are characterized neuropathologically by aggregates of abnormal filamentous proteins that progressively accumulate in selectively vulnerable regions of the central nervous system (CMS). Different disease proteins form distinct CNS lesions that are diagnostic hallmarks of specific neurodegenerative disorders. While the clinical variants of frontotemporal lobar degeneration. (FTLD) or frontotemporal dementia (FTD) syndromes are relatively well defined, characterization of their underlying neuropathology is incomplete. Indeed, clinically defined FTLD syndromes may be associated with several different neuropathological substrates, including Alzheimer's disease (AD) plaques and tangles, but the relationship of clinical FTLD syndromes to specific neuropathologies is incompletely understood. Thus, postmortem examination of CNS tissues from FTLD patients is essential for developing accurate and reliable clinicopathological FTLD diagnostic criteria, as well as to provide highly characterized CNS tissue samples for research. The growing cohort of FTLD patients followed in Core A of this Program Project Grant (PPG) and the increasing number of postmortem brains/spinal cords obtained from these patients provide a compelling rationale for the Neuropathology Core (Core B) in this PPG. Thus, the Aims of Core B support the goals of this PPG by providing diagnostic neuropathology, CNS tissue banking, database tracking of samples and neuropathology data on all FTLD subjects followed in Core A of this PPG who consent to autopsy as well as by providing advice to PPG investigators on the use of neuropathology data or samples from this Core in their research.
| Dijkstra, Anke A; Lin, Li-Chun; Nana, Alissa L et al. (2018) Von Economo Neurons and Fork Cells: A Neurochemical Signature Linked to Monoaminergic Function. Cereb Cortex 28:131-144 |
| Mok, Sue-Ann; Condello, Carlo; Freilich, Rebecca et al. (2018) Mapping interactions with the chaperone network reveals factors that protect against tau aggregation. Nat Struct Mol Biol 25:384-393 |
| Erkkinen, Michael G; Zúñiga, Raquel Gutiérrez; Pardo, Cristóbal Carnero et al. (2018) Artistic Renaissance in Frontotemporal Dementia. JAMA 319:1304-1306 |
| Schneider, Raphael; McKeever, Paul; Kim, TaeHyung et al. (2018) Downregulation of exosomal miR-204-5p and miR-632 as a biomarker for FTD: a GENFI study. J Neurol Neurosurg Psychiatry 89:851-858 |
| Ljubenkov, Peter A; Staffaroni, Adam M; Rojas, Julio C et al. (2018) Cerebrospinal fluid biomarkers predict frontotemporal dementia trajectory. Ann Clin Transl Neurol 5:1250-1263 |
| La Joie, Renaud; Bejanin, Alexandre; Fagan, Anne M et al. (2018) Associations between [18F]AV1451 tau PET and CSF measures of tau pathology in a clinical sample. Neurology 90:e282-e290 |
| Kim, Eun-Joo; Brown, Jesse A; Deng, Jersey et al. (2018) Mixed TDP-43 proteinopathy and tauopathy in frontotemporal lobar degeneration: nine case series. J Neurol 265:2960-2971 |
| Henry, Maya L; Hubbard, H Isabel; Grasso, Stephanie M et al. (2018) Retraining speech production and fluency in non-fluent/agrammatic primary progressive aphasia. Brain 141:1799-1814 |
| Nana, Alissa L; Sidhu, Manu; Gaus, Stephanie E et al. (2018) Neurons selectively targeted in frontotemporal dementia reveal early stage TDP-43 pathobiology. Acta Neuropathol : |
| Vatsavayai, Sarat C; Nana, Alissa L; Yokoyama, Jennifer S et al. (2018) C9orf72-FTD/ALS pathogenesis: evidence from human neuropathological studies. Acta Neuropathol : |
Showing the most recent 10 out of 607 publications
